Company

Ever Supreme Bio Technology Co. Ltd

Headquarters: Taichung, Taiwan

Employees: 94

TWSE: 6712 +0.57%

Market Cap

TW$15.58 Billion

TWD as of July 1, 2024

US$478.5 Million

Market Cap History

Ever Supreme Bio Technology Co. Ltd market capitalization over time

Evolution of Ever Supreme Bio Technology Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Ever Supreme Bio Technology Co. Ltd

Detailed Description

Ever Supreme Bio Technology Co., Ltd engages in the research and development of cell gene therapies based on immune cells and stem cells. Its products in development include UMSC01, a drug candidate in Phase 2 clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase 3 clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product in Phase 1 clinical trials for use in the treatment of triple-negative breast cancer; and gene modified mesenchymal stem cells and fucoidan nanoparticles for use in the treatment of malignant tumor. The company was founded in 2016 and is based in Taichung, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Ever Supreme Bio Technology Co. Ltd has the following listings and related stock indices.


Stock: TWSE: 6712 wb_incandescent

Details

Headquarters:

Room A, No. 573, Taiwan Boulevard

10th Floor Sec. 2 West District

Taichung, 403

Taiwan

Phone: 886 4 2325 2888